Drug Delivery
The Drug Delivery Special Interest Group will deal with the science and technology of controlled release of active agents from delivery systems. Controlled drug release is achieved by the use of diffusion, chemical reactions, dissolutions or osmosis, used either singly or in combination. While the vast majority of such delivery devices are based on polymers, controlled release can also be achieved by the use of mechanical pumps. In a broader sense, controlled release also involves control over the site of action of the active agent, using the active agent using pro-drugs, targetable water soluble polymers or various microparticulate systems. Relevant aspects of toxicology, bioavailability, pharmacokinetics, and biocompatibility are also included.
Objectives:
- Provide forums for presentations and exchange of knowledge at SFB through sponsoring symposia and sessions.
- Publicize member activities in the Biomaterials Forum.
- Provide career and professional development resources through networking and mentoring relationships to facilitate career transitions from graduate school to industrial and academic careers and beyond.
- Establish stronger interactions with members in the SIG, other SIGs, and other professional societies.
Activities
- suggesting, organizing, and implementing symposia, workshops, tutorials, and general scientific sessions at the SFB Annual Meeting and other SFB-sponsored meetings
- providing networking opportunities for researchers who work at the interface of pharmaceutical science, drug delivery and biomaterials
- promoting interactions between academia, clinicians, government, and industry in areas that impact drug delivery
- generating a one stop resource for funding opportunities and needs to better match drug delivery researchers with the funding agencies
- enhancing education in the area of biomaterials and drug delivery, by contributing articles to relevant publications, sharing educational materials and organizing educational sessions at meetings
- collaborating with other SIGs to further the goals of the Society as a whole, and to promote advances in biomedical materials research in a broad range of applications
Officers
Chair: John Clegg, Ph.D.
Assistant Professor
University of Oklahoma
101 David L. Boren Blvd. #2069
Norman, OK 73019
t: (405) 325-5318
e: clegg@ou.edu
Vice Chair: John Martin, Ph.D.
Assistant Professor
University of Cincinnati
2901 Woodside Dr
Cincinnati, OH 45219
e: martinjr@uc.edu
Secretary/Treasurer: Dhanashree Surve, Ph.D.
Assistant Scientist
Diabetes Research Institute, University of Miami
1450 NW 10th Avenue
Miami, FL 33125
t: (781) 520-5699
e: dhs121@miami.edu
Program Chair: Aliasger Salem, Ph.D.
Associate Vice President/Bighley Chair & Professor
University of Iowa
115 S Grand Avenue
Iowa City, IA 52241
e: aliasger-salem@uiowa.edu
PostDoc Representative: Brett Pogostin, PhD
Massachusetts Institute of Technology
e: bpogo@mit.edu
Student Representative: Paul Nana Kwame Sagoe
Syracuse University
e: pnsagoe@syr.edu
Biomaterials Forum Reporter: Dhanashree Surve
Diabetes Research Institute, University of Miami
1450 NW 10th Avenue, 2018 Office
Miami, FL 33125
t: (781) 520-5699
e: dhs121@miami.edu
Web Representative: Elham Taherian
University of Iowa
t: (319) 936-5647
e: elham-taherian@uiowa.edu
Industry Representative: Kenneth Sims
Battelle Memorial Institute
505 King Avenue
Columbus, OH 43201
t: (614) 424-4421
e: simsk@battelle.org
Journal Advocate: Eun Ji Chung
Professor
Univ. of Southern California
1042 Downey Way, DRB 140
Los Angeles, CA 90089
e: eunchung@usc.edu
Past Chair: Kevin J. McHugh, PhD
Assistant Professor of Bioengineering
CPRIT Scholar in Cancer Research
Departments of Bioengineering and Chemistry
​Rice University
t: (713) 348-8089
e: kevin.mchugh@rice.edu